Center for Biologics Evaluation and Research – Food and Drug Administration · company speakers →
Dr. Gavin will outline the regulatory considerations for when a genome engineering trial is reviewed by the FDA.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →